Tag: drug approval

November 16, 2023
FDA Approves New Formulation of Combogesic

The acetaminophen and ibuprofen combination was approved for IV use, and as an adjunct to opioid therapy for the treatment of pain.

READ MORE
October 19, 2023
New Depression Product and Diabetes Generic Approvals

Exuua was approved for major depressive disorder, while two diabetes medications receive generic approvals.

READ MORE
March 21, 2023
FDA Approves Combogesic for Short Term Management of Mild to Moderate Pain

A new combination of acetaminophen and ibuprofen will soon hit the market.

READ MORE
December 21, 2022
FDA Approves Drug That Can Delay Onset of Type 1 Diabetes

Tzield (teplizumab-mzwv) injections can delay onset by several months or years.

READ MORE
September 28, 2022
Auvelity Approved for Major Depressive Disorder

This antidepressant can yield results as soon as one week, which could generate popularity.

READ MORE
July 30, 2022
There Is No “Set it and Forget It” Amid Prescription Drug Trends

As opioid prescribing continues to decline, more nuanced and population-specific drug trends emerge as cost drivers.

READ MORE
March 28, 2022
FDA Approves Fleqsuvy for Spasticity

A new muscle relaxant for the treatment of spasticity, including from spinal cord injuries.

READ MORE
January 17, 2022
FDA Approves Yusimry as a Biosimilar to Humira

This autoimmune drug was approved for various arthritic and autoimmune diseases.

READ MORE
November 17, 2021
FDA Approves Zimhi and Seglentis

A new naloxone drug and a new opioid-NSAID combination.

READ MORE
October 21, 2021
New Drugs, Generics, and a COVID-19 Treatment Update

A new migraine medication, various generics, and more.

READ MORE
lockenvelopephone-handsetmagnifiermenucross-circle